I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Todenhöfer, Tilman
197
results:
Format
Online (197)
Mediatypes
Articles (Online) (127)
Bookchapter (Online) (3)
OpenAccess-fulltext (66)
Thesis (Online) (1)
Languages
german (17)
english (170)
Sorted by: Relevance
Sorted by: Year
?
1
Pembrolizumab and Enzalutamide in Patients with Abiraterone..:
Yu, Evan Y.
;
Berry, William R.
;
Gurney, Howard
...
European Urology Oncology. 7 (2024) 3 - p. 509-518 , 2024
Link:
https://doi.org/10.1016/..
?
2
Interleukin-1β/Interleukin (IL)-1-Receptor-Antagonist (IL1-..:
Vukovic, Marko
;
Chamlati, Jorge M.
;
Hennenlotter, Jörg
...
International Journal of Molecular Sciences. 25 (2024) 4 - p. 2447 , 2024
Link:
https://doi.org/10.3390/..
?
3
Simulation of the effects of molecular urine markers in fol..:
Benderska-Söder, Natalya
;
Ecke, Thorsten
;
Kleinlein, Lisa
...
Urologic Oncology: Seminars and Original Investigations. 42 (2024) 8 - p. 229-235 , 2024
Link:
https://doi.org/10.1016/..
?
4
Derazantinib alone and with atezolizumab in metastatic urot..:
Necchi, Andrea
;
Ramlau, Rodryg
;
Falcón González, Alejandro
...
JNCI Cancer Spectrum. 8 (2024) 3 - p. , 2024
Link:
https://doi.org/10.1093/..
?
5
Pembrolizumab plus Abiraterone Acetate and Prednisone in Pa..:
Yu, Evan Y.
;
Ferrario, Cristiano
;
Linch, Mark D.
...
European Urology Oncology. , 2024
Link:
https://doi.org/10.1016/..
?
6
Urine biomarkers in bladder cancer — current status and fut..:
Maas, Moritz
;
Todenhöfer, Tilman
;
Black, Peter C.
Nature Reviews Urology. 20 (2023) 10 - p. 597-614 , 2023
Link:
https://doi.org/10.1038/..
?
7
Corrigendum to "Pembrolizumab plus Olaparib in Patients wit..:
Yu, Evan Y.
;
Piulats, Josep M.
;
Gravis, Gwenaelle
...
European Urology. 83 (2023) 3 - p. e87 , 2023
Link:
https://doi.org/10.1016/..
?
8
Discriminative capacity of guideline recommendations in the..:
Kuckuck, Eva Charlotte
;
Hennenlotter, Jörg
;
Todenhöfer, Tilman
...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 5 - p. 254.e1-254.e8 , 2023
Link:
https://doi.org/10.1016/..
?
9
Pembrolizumab plus Olaparib in Patients with Metastatic Cas..:
Yu, Evan Y.
;
Piulats, Josep M.
;
Gravis, Gwenaelle
...
European Urology. 83 (2023) 1 - p. 15-26 , 2023
Link:
https://doi.org/10.1016/..
?
10
Triptorelinembonat besser alle sechs statt alle drei Monate..:
Rexer, Heidrun
;
Todenhöfer, Tilman
;
Graefen, Markus
Uro-News. 27 (2023) 4 - p. 64-65 , 2023
Link:
https://doi.org/10.1007/..
?
11
Differential Expression and Clinical Relevance of C-X-C Mot..:
Maas, Moritz
;
Kurcz, Aymone
;
Hennenlotter, Jörg
...
International Journal of Molecular Sciences. 24 (2023) 6 - p. 5227 , 2023
Link:
https://doi.org/10.3390/..
?
12
Bladder preservation after neoadjuvant therapy – 2021 IBCN ..:
Hensley, Patrick J.
;
Seiler, Roland
;
Herr, Harry
...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 7 - p. 307-312 , 2023
Link:
https://doi.org/10.1016/..
?
13
IBCN Seminar Series 2021: Circulating tumor DNA in bladder ..:
Christensen, Emil
;
Wyatt, Alexander W.
;
Galsky, Matthew D.
...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 7 - p. 318-322 , 2023
Link:
https://doi.org/10.1016/..
?
14
Adjuvante Phase-III-Studie für Patienten mit lokal fortgesc..:
Rexer, Heidrun
;
Todenhöfer, Tilman
;
Graefen, Markus
Forum. 38 (2023) 4 - p. 336-337 , 2023
Link:
https://doi.org/10.1007/..
?
15
25 years International Bladder Cancer Network (IBCN): The p..:
Dyrskjøt, Lars
;
Vlahou, Antonia
;
Black, Peter C.
...
Urologic Oncology: Seminars and Original Investigations. 41 (2023) 7 - p. 302-306 , 2023
Link:
https://doi.org/10.1016/..
1-15